Electrode re-implantation helps some Parkinson's disease patients

May 12, 2008

A study of seven patients with Parkinson’s disease suggests that those who have poor results following implantation of electrodes to stimulate the brain may benefit from additional surgery to correct the electrode placement, according to a report in the May issue of Archives of Neurology.

Implanting electrodes that stimulate the subthalamic nucleus, a region deep in the brain potentially related to impulsivity, is effective in reducing medication doses and improving the symptoms of Parkinson’s disease, according to background information in the article. With this treatment, medication doses are often reduced by 50 percent to 65 percent, and scores on scales measuring motor function (generally impaired in Parkinson’s disease) typically improve by 40 percent to 70 percent. However, sometimes the surgery is less effective.

“The principal cause of these poor results arises from imprecision of electrode placement, leading to non-stimulation of the target as required,” the authors write. “Misplacement of the electrode by only a few millimeters may have occurred.”

Mathieu Anheim, M.D., of the University Hospital A. Michallon, Strasbourg, France, and colleagues studied seven consecutive patients age 49 to 70 with Parkinson’s disease who, despite electrode implantation, continued to experience severe symptoms. The patients were operated on again and the electrodes were re-implanted 12 to 23 months after the original surgery. Motor scores and medication doses were assessed one year after the second procedure.

All patients except for one displayed improvement after the second surgery. When they were not on medication, treatment improved the patient’s motor scores by 26.7 percent following the first operation and 59.4 percent following the second procedure. Their dose of levodopa, a medication treating Parkinson’s disease, decreased from 1,202 milligrams to 534 milligrams. The average distance between the electrodes and the target point of stimulation—a location in the subthalamic nucleus identified by evaluating electrode placement in patients whose surgery was successful—decreased from 5.4 to 2 millimeters. The shorter this distance, the greater the patient’s improvement in motor scores.

Source: JAMA and Archives Journals

Explore further: Novel therapeutic agent for Tamiflu-resistant pH1N1 influenza virus discovered

add to favorites email to friend print save as pdf

Related Stories

Fighting Parkinson's with carbon nanoparticles

Nov 29, 2011

One of the problems affecting the human nervous system is dopamine deficiency. But testing of dopamine concentration is costly and requires sophisticated equipment not available in a doctor's office. Enter ...

Recommended for you

User comments : 0

More news stories

New breast cancer imaging method promising

The new PAMmography method for imaging breast cancer developed by the University of Twente's MIRA research institute and the Medisch Spectrum Twente hospital appears to be a promising new method that could ...

Breast cancer replicates brain development process

New research led by a scientist at the University of York reveals that a process that forms a key element in the development of the nervous system may also play a pivotal role in the spread of breast cancer.

Research proves nanobubbles are superstable

The intense research interest in surface nanobubbles arises from their potential applications in microfluidics and the scientific challenge for controlling their fundamental physical properties. One of the ...

Using antineutrinos to monitor nuclear reactors

When monitoring nuclear reactors, the International Atomic Energy Agency has to rely on input given by the operators. In the future, antineutrino detectors may provide an additional option for monitoring. ...